Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMTRICITABINE for Prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where EMTRICITABINE was used for Prophylaxis.

Most Reported Side Effects for EMTRICITABINE

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 609 16.4% 137 52
Drug resistance 370 10.0% 3 32
Virologic failure 331 8.9% 11 25
Immune reconstitution inflammatory syndrome 262 7.1% 49 140
Exposure during pregnancy 212 5.7% 19 37
Drug ineffective 196 5.3% 30 44
Pathogen resistance 166 4.5% 0 12
Viral mutation identified 161 4.3% 2 6
Maternal exposure during pregnancy 160 4.3% 26 49
Death 154 4.1% 154 24
Treatment noncompliance 136 3.7% 7 35
Treatment failure 133 3.6% 4 6
Premature baby 127 3.4% 21 14
Drug interaction 106 2.9% 5 34
Off label use 91 2.5% 45 60

Other Indications for EMTRICITABINE

Hiv infection (2,362) Product used for unknown indication (477) Antiretroviral therapy (170) Prophylaxis against hiv infection (167) Acquired immunodeficiency syndrome (49) Hepatitis b (46) Hiv-2 infection (37) Maternal exposure timing unspecified (34) Hiv infection who clinical stage iii (28) Chronic hepatitis b (26)

Other Drugs Used for Prophylaxis

PEGFILGRASTIM (7,424) HUMAN C1-ESTERASE INHIBITOR (5,950) DENOSUMAB (4,541) SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197) ASPIRIN (2,083) VALACYCLOVIR (1,574) PANTOPRAZOLE (1,502) VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444) CLOPIDOGREL BISULFATE (1,296) ENOXAPARIN (1,278)

Related Pages

EMTRICITABINE Full Profile All Prophylaxis Drugs EMTRICITABINE Demographics EMTRICITABINE Timeline